Advances in Clinical Application of Liquid Biopsy in Non-small Cell Lung Cancer
Lung cancer, with the highest incidence in China, is the leading cause of death in cancer patients. Of these, about 85% are patients with non-small cell lung cancer (NSCLC). Therefore, the diagnosis and treatment of patients with lung cancer have always been a top priority nowadays. Fluid biopsy has...
Sábháilte in:
| Príomhchruthaitheoirí: | , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Chinês |
| Foilsithe / Cruthaithe: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2021-10-01
|
| Sraith: | Chinese Journal of Lung Cancer |
| Ábhair: | |
| Rochtain ar líne: | http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.33 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|